Clinical Trials

Study Title:
A Phase 2, Randomized Study to Evaluate the Safety, Efficacy and Optimal dose of ABBV-400 in Combination with Fluorouracil (5-FU), Folinic Acid and Bevacizumab in Previously Treated Subjects with Unresectable Metastatic Colorectal Cancer (mCRC)

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Albert Lockhart, at lockhara@musc.edu. Study Coordinator, Bria Sanders, at sandebri@musc.edu. Trial opened at the following institutions: Medical University of South Carolina